EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis

Ying Wu, Yuyu You, Tingsong Jiang, Yuqi He, Qingchi Fan, Xinlei Zeng, Ting Li, Yuxing Lu, Liang Qi, Fengxia Zhou, Lingyu Sun, Danyang Wang und 4 weitere

Advanced Science · 2025-03 · 12 (9)

DOI: 10.1002/advs.202406654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.01.2025. Verfasst von Ying Wu und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China. Hauptthemen laut MEDLINE: Macrophages, Phagocytosis, Sialic Acid Binding Immunoglobulin-like Lectins, Desmoglein 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Key Laboratory of Drug Nonclinical Evaluation and Research, Science and Technology Projects in Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells present sialylated glycoconjugates that modulate the activity of various immune cells within the tumor microenvironment through trans interaction with immunosuppressive Siglec receptors. Identifying counter receptors for Siglecs can provide valuable targets for cancer immunotherapy, but it presents significant challenges. Here, the identification of DSG2 (Desmoglein 2) as a dominant counter receptor of Siglec‐9 in melanoma cells is reported, using a workflow that combines the strength of proximity labeling and the advantage of CRISPR knockout screening. It is further demonstrated that the interaction between DSG2 and Siglec‐9 is mainly dependent on sialic acid‐bearing N ‐glycans on DSG2. Importantly, blocking trans interaction between DSG2 and Siglec‐9 significantly enhances macrophage phagocytosis of melanoma cells and, to a lesser extent, other cancer cells. The work thus suggests sialylated DSG2 as a potential “don't eat me” signal molecule with therapeutic potentials in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesPhagocytosisSialic Acid Binding Immunoglobulin-like LectinsDesmoglein 2MelanomaAntigens, CDHumansCell Line, TumorTumor MicroenvironmentGenetic TestingAnimals

Stichwörter der Autor:innen

DSG2genetic screeningphagocytosisproximity labelingsiglec‐9

Substanzen

Sialic Acid Binding Immunoglobulin-like LectinsDesmoglein 2SIGLEC9 protein, humanDSG2 protein, humanAntigens, CD

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510275, China.
  • Department of Blood Transfusion, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510000, China.
  • Institute of Human Virology, Department of Pathogen Biology and Biosecurity, and Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 5100…
  • State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China.
  • Guangdong Provincial Key Laboratory of Drug Non-Clinical Evaluation and Research, Guangzhou, 510006, China.

ORCID-Profile: Yanqiu Yuan, Yang Mao

Förderung

  • National Natural Science Foundation of China
  • Guangdong Provincial Key Laboratory of Drug Nonclinical Evaluation and Research
  • Science and Technology Projects in Guangzhou
  • National Key R&D Program of Ministry of Science and Technology of China

Zitieren

APA

Wu, Y., You, Y., Jiang, T., He, Y., Fan, Q., Zeng, X., Li, T., Lu, Y., Qi, L., Zhou, F., Sun, L., Wang, D., Zou, Y., Zhang, G., Yuan, Y., & Mao, Y. (2025). Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis. Advanced Science, 12(9). https://doi.org/10.1002/advs.202406654

Vancouver

Wu Y, You Y, Jiang T, He Y, Fan Q, Zeng X, et al. Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis. Advanced Science. 2025;12(9). doi:10.1002/advs.202406654

BibTeX
@article{Wu2025,
  author = {Wu, Ying and You, Yuyu and Jiang, Tingsong and He, Yuqi and Fan, Qingchi and Zeng, Xinlei and Li, Ting and Lu, Yuxing and Qi, Liang and Zhou, Fengxia and Sun, Lingyu and Wang, Danyang and Zou, Yong and Zhang, Guigen and Yuan, Yanqiu and Mao, Yang},
  title = {Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {9},
  doi = {10.1002/advs.202406654}
}
Kostenlos starten →